Main state industrial policy measures for the pharmaceutical industry of the Russian Federation

IF 0.2 Q4 MEDICINE, GENERAL & INTERNAL

Bulletin of Russian State Medical University Pub Date : 2023-02-01 DOI:10.24075/brsmu.2023.007

TY Gaydin, EV Geller, S. Rozhnova, T. Gaydina

引用次数: 0

Abstract

Due to the changes in the modern world, it is necessary to develop the domestic pharmaceutical industry, which is a task especially important in the context of implementation of the import substitution policy. The article classifies the main measures the state industrial policy has for the pharmaceutical industry; these measures cover informational and consulting aspects, research and technical parts, innovations and economic matters. Practical actions and their possible consequences are considered for each group of the industrial policy measures: encouragement of domestic consumption, regulation of imports, stimulation and support of exports, stimulation of technological development, public-private partnerships, support of the development of intersectoral territorial production complexes (clusters), direct state support of investment activities, tax incentives for investors.

查看原文本刊更多论文

俄罗斯联邦制药行业的主要国家产业政策措施

由于现代世界的变化，有必要发展国内制药工业，这在实施进口替代政策的背景下是一项特别重要的任务。文章对国家产业政策对医药行业的主要措施进行了分类；这些措施包括信息和咨询、研究和技术、创新和经济事项。每一组产业政策措施都考虑了实际行动及其可能产生的后果：鼓励国内消费、监管进口、刺激和支持出口、刺激技术发展、公私伙伴关系、支持跨部门地区生产综合体（集群）的发展、，国家直接支持投资活动，为投资者提供税收优惠。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Bulletin of Russian State Medical University MEDICINE, GENERAL & INTERNAL-

CiteScore

0.80

自引率

0.00%

发文量

期刊介绍： Bulletin of Russian State Medical University (Bulletin of RSMU, ISSN Print 2500–1094, ISSN Online 2542–1204) is a peer-reviewed medical journal of Pirogov Russian National Research Medical University (Moscow, Russia). The original language of the journal is Russian (Vestnik Rossiyskogo Gosudarstvennogo Meditsinskogo Universiteta, Vestnik RGMU, ISSN Print 2070–7320, ISSN Online 2070–7339). Founded in 1994, it is issued once every two months publishing articles on clinical medicine and medical and biological sciences, first of all oncology, neurobiology, allergy and immunology, medical genetics, medical microbiology and infectious diseases. Every issue is thematic. Deadlines for manuscript submission are announced in advance. The number of publications on topics in spite of the issue topic is limited. The journal accepts only original articles submitted by their authors, including articles that present methods and techniques, clinical cases and opinions. Authors must guarantee that their work has not been previously published elsewhere in whole or in part and in other languages and is not under consideration by another scientific journal. The journal publishes only one review per issue; the review is ordered by the editors.